Investigational Liquid Biopsy Shows High Sensitivity for Early-Stage Pancreatic Cancer
Audio narration · Coming soon
The investigational liquid biopsy PANXEON demonstrated high sensitivity in detecting stage 1 and 2 pancreatic cancer while maintaining a low false positive rate. This development could improve early diagnosis of pancreatic cancer, which is critical for better patient outcomes.
Why this matters
PRISM scored this story 65/100 for interest.
Originally published by gnews